Can-Fite Biopharma Ltd - ADR
ASE:CANF 3:59:54 PM EDT
| Market Cap (Intraday) | 30.71M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.21 |
| 50-Day MA | $1.25 |
| 200-Day MA | $1.77 |
Can-Fite Biopharma Ltd - ADR Stock, ASE:CANF
10 Bareket Street, Kiryat Matalon, Petach Tikva, HaMerkaz 49170
Israel
Phone: +972.3.924.1114
Number of Employees: 8
Description
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for cancer and inflammatory diseases. Its product pipeline includes Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.